Search for Clinical Trial Results

Sponsored By

Metal Metabolism, Inborn Errors - 6 Studies Found

Status Study
Recruiting Study Name: Study of ALXN1101 in Neonates With Molybdenum Cofactor Deficiency (MOCD) Type A
Condition: Molybdenum Cofactor Deficiency, Type A
Date: 2015-12-03
Interventions: Drug: ALXN1101
Active, not recruiting Study Name: Safety & Efficacy Study of ALXN1101 in Pediatric Patients With MoCD Type A Currently Treated With rcPMP
Condition: Molybdenum Cofactor Deficiency, Type A
Date: 2014-01-09
Interventions: Drug: ALXN1101 IV infusion
Completed Study Name: Phase 1 Single Dose Study of ALXN1101 in Healthy Volunteers
Condition:
  • Molybdenum Cofactor Deficiency (MoCD)
  • Rare Autosomal Recessive Disorder
  • Drug: ALXN1101 Randomized to r
Recruiting Study Name: Apotransferrin in Atransferrinemia
Condition: Congenital Atransferrinemia
Date: 2013-02-20
Interventions: Drug: Human apotransferrin intravenous infusion
Completed Study Name: A Retrospective, Observational, Noninterventional Data Collection Study for Patients With Molybdenum Cofactor Deficiency Who Have Been Previously Treated With Cyclic Pyranopterin Monophosphate (cPMP)
Condition: Molybdenum Cofactor Deficiency
Date: 2012-07-12
Withdrawn Study Name: Study of cPMP (Precusor Z) to Treat Molybdenum Cofactor Deficiency (MoCD) Type A
Condition: Molybdenum Cofactor Deficiency Type A
Date: 2009-07-10
Interventions: Drug: cPMP Intravenous solution administered daily. Dose titrated from 80 μg/kg on Days 1-12 to 120